Questa Capital: $397 Million Fund III Closed To Invest In Healthcare Companies

By Amit Chowdhry • Aug 27, 2023

Questa Capital Management – a venture growth equity firm exclusively dedicated to the healthcare industry – recently announced the final close of Questa Capital Partners III, LP, with $397 million of capital commitments, bringing the firm’s aggregate committed capital to over $1 billion.

This fund will invest selectively in a portfolio of growth companies in three healthcare sectors of focus: services, technology, and medical devices. The firm has an investment team of ten led by Founder Ryan Drant and Managing Partners Brad Sloan and Shawn Conway. It currently manages eighteen portfolio companies across its three healthcare sectors.

The fund secured commitments from a diversified blue-chip investor base comprised of leading endowments, family offices, foundations, consultants, pension plans, and fund-of-funds.

Questa Capital’s record of being an active and collaborative partner for the companies it invests in is a hallmark of its approach. And the Questa team brings deep sector expertise in healthcare services, technology, and medical devices and a deep network and industry experience to help guide portfolio companies toward leading market positions and accelerated growth.

KEY QUOTES:

“We are extremely pleased to close on Fund III despite a challenging fundraising environment. We are both grateful for the strong interest and ongoing support from our existing investors and pleased to be starting long-term relationships with a small group of exceptional new limited partners.  We are honored to work closely with our portfolio companies, including marquee companies like Dispatch Health, Cortica, Medrio, and Calyxo.  We are also energized by the opportunity set we see in the market and look forward to continuing to build differentiated and high-growth healthcare companies in close collaboration with strong management teams.  Questa will continue to partner with companies that share our vision and passion to improve clinical outcomes, efficiency, safety, and the patient experience to help address critical challenges in our healthcare system.”

— Questa Founder and Managing Partner Ryan Drant

“As Cortica continues to grow rapidly, Questa Capital has been an exceptional partner for our company as we build our team, broaden our relationships, and execute on our geographic expansion. Ryan and Brad are both extremely valued leaders on the Cortica board of directors.  We congratulate them on their success in raising Fund III and look forward to our continued close collaboration.”

— Neil Hattangadi MD, CEO and Co-Founder of Cortica